Preliminary study of Gd-EOB-DTPA contrast-enhanced magnetic resonance imaging for determining gross tumor volume in hepatocellular carcinoma radiotherapy
Kangning Meng, Guanzhong Gong, Ruozheng Wang, Yong Yin

TL;DR
This study shows that MRI with a specific contrast agent can better define liver tumor volumes for radiotherapy when images are taken more than 20 minutes after injection.
Contribution
The study demonstrates that delayed contrast-enhanced MRI improves tumor boundary definition in hepatocellular carcinoma radiotherapy planning.
Findings
CE-T1WI images acquired >20 min after Gd-EOB-DTPA injection showed highest signal intensity contrast between HCC and liver tissue.
GTV volumes determined from delayed images were significantly larger than earlier time points.
Dice similarity coefficients indicated moderate to strong agreement between GTV contours across different imaging phases.
Abstract
The aim of this study was to evaluate the feasibility of gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid (Gd-EOB-DTPA) contrast-enhanced magnetic resonance imaging (CE-MRI) for determining the gross tumor volume (GTV) of hepatocellular carcinoma (HCC). A retrospective analysis was conducted on 12 patients diagnosed with HCC (18 lesions) who received radiotherapy and underwent magnetic resonance (MR) simulation. Six series images, including MR T1-weighted image (T1WI) and contrast-enhanced T1WI (CE-T1WI) at 15 s, 45 s, 75 s, 150 s, and >20 min after Gd-EOB-DTPA injection, were obtained, and the GTV was determined in the different temporal images. The differences in mean signal intensity (SI), SI contrast between the HCC and liver tissue, volume and shape of HCC GTV among different phases were compared. (1) The mean SI of liver tissue reached its peak enhancement at >20 min,…
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
Figure 8Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsHepatocellular Carcinoma Treatment and Prognosis · MRI in cancer diagnosis · Lanthanide and Transition Metal Complexes
